CompletedNot Applicable

Intra-individual Comparison of Conventional and Digital PET/CT Scanners

Netherlands225 participantsStarted 2018-01-08

Plain-language summary

In this study, the investigators will analyze the impact of digital PET/CT on the final diagnostic conclusion of the scan in patients with lung cancer, breast cancer, esophageal cancer and a group of mescellaneous cancers.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria In order to be eligible to participate in this study, a subject must meet all of the following criteria: * referred to Isala for a clinically indicated FDG-PET/CT scan * suspected or proven lung cancer, esophageal cancer, breast cancer or miscellaneous cancer, either as a primary diagnosis or follow-up study * signed informed consent Exclusion criteria A potential subject who meets any of the following criteria will be excluded from participation in this study: * age \< 18 years * incapacitated adults * prisoners * pregnant patients * unable to undergo two consecutive PET/CT scans

What they're measuring

Diagnostic outcome of the PET/CT study

Timeframe: approximately 2 hours

Trial details

NCT IDNCT03457506

SponsorIsala

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-09-13

View on ClinicalTrials.gov More Breast Cancer trials